Skip to main content
HBIO
NASDAQ Life Sciences

Harvard Bioscience Posts $0.58 Per-Share Q3 Loss

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$9.09
Mkt Cap
$41.38M
52W Low
$4
52W High
$9.32
52W Position info
127% above low
Off High info
2.5% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

HBIO has more than doubled off its 52-week low of $4 on elevated volume (2.3× avg).

Summary

Harvard Bioscience reported a third-quarter loss of $2.62M, or $0.58 per share, on revenue of $22.2M, up 8% year over year and ahead of estimates. The company is coming off Q2 2026 revenue of $22.7M, up 11% year over year, when it raised full-year revenue guidance — so a $0.58 quarterly loss is a sharp swing against that improving top-line trend. With a market cap near $41M and the stock trading near its 52-week high of $9.32, the loss lands on a name that has already run hard. High debt costs and cash burn flagged in the last 10-Q remain the pressure points.

At the time of this announcement, HBIO was trading at $9.09 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $41.4M. The 52-week trading range was $4.00 to $9.32. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

HBIO - Latest Insights

HBIO
Nov 10, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.09
Real-time Price: $9.09 info
Change: $0 (0%) info
Market Cap: $41.38M info
HBIO
Nov 10, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.09
Real-time Price: $9.09 info
Change: $0 (0%) info
Market Cap: $41.38M info
HBIO
Aug 11, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $6.13
Real-time Price: $9.09 info
Change: +$2.96 (+48%) info
Market Cap: $41.38M info
HBIO
Aug 11, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.41
Real-time Price: $9.09 info
Change: +$2.68 (+42%) info
Market Cap: $41.38M info
HBIO
Jun 02, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.46
Real-time Price: $9.09 info
Change: +$2.63 (+41%) info
Market Cap: $41.38M info